What's your institution's policy for handling the following situation: A physician wishes to prescribe an FDA-approved drug for an off-label indication for which there is little literature support.

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

Expanded role for the P & T Committee: Gaining patient consent for off-label drug use

Newsletter